Amneal Pharmaceuticals Inc AMRX:NYSE

RT Quote | NYSE | USD
Last | 10/27/21 EDT
5.34quote price arrow down-0.20 (-3.61%)
Volume
688,844
52 week range
3.90 - 7.45
Loading...
  • Open5.50
  • Day High5.50
  • Day Low5.27
  • Prev Close5.34
  • 52 Week High7.45
  • 52 Week High Date03/22/21
  • 52 Week Low3.90
  • 52 Week Low Date11/30/20

Key Stats

  • Market Cap1.609B
  • Shares Out301.39M
  • 10 Day Average Volume0.46M
  • Dividend-
  • Dividend Yield-
  • Beta1.18
  • YTD % Change16.85

KEY STATS

  • Open5.50
  • Day High5.50
  • Day Low5.27
  • Prev Close5.34
  • 52 Week High7.45
  • 52 Week High Date03/22/21
  • 52 Week Low3.90
  • 52 Week Low Date11/30/20
  • Market Cap1.609B
  • Shares Out301.39M
  • 10 Day Average Volume0.46M
  • Dividend-
  • Dividend Yield-
  • Beta1.18
  • YTD % Change16.85

RATIOS/PROFITABILITY

  • EPS (TTM)0.05
  • P/E (TTM)98.52
  • Fwd P/E (NTM)-
  • EBITDA (TTM)413.853M
  • ROE (TTM)2.83%
  • Revenue (TTM)2.058B
  • Gross Margin (TTM)35.82%
  • Net Margin (TTM)0.86%
  • Debt To Equity (MRQ)824.10%

EVENTS

  • Earnings Date11/03/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Amneal Pharmaceuticals Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Amneal Pharmaceuticals, Inc. is a pharmaceutical company. The Company is engaged in the developing, manufacturing, marketing and distributing high-value generic and branded specialty pharmaceutical products across a broad array of dosage forms and therapeutic areas. It operates in three segments, which include Generics, Specialty and AvKARE. The Generics segment provides prescription pharmaceutical products. The Specialty Pharma is engaged in the development, promotion, sale...
Paul Meister
Non-Executive Chairman
Chirag Patel
President
Anastasios Konidaris
Chief Financial Officer
Andrew Boyer
Executive Vice President
Joseph Todisco
Executive Vice President
Address
400 Crossing Blvd Fl 3
Bridgewater, NJ
08807-2863
United States

Top Peers

SYMBOLLASTCHG%CHG
EBS
Emergent BioSolutions Inc
48.23-2.15-4.27%
ENDP
Endo International PLC
4.19-0.19-4.34%
PAHC
Phibro Animal Health Corp
21.94-0.54-2.40%
PBH
Prestige Consumer Healthcare Inc
58.50-1.28-2.14%
SUPN
Supernus Pharmaceuticals Inc
29.36-0.67-2.23%